Trend Innovations issues $125,100 convertible note to 1800 Diagonal Lending at 8% interest

AVAI BIO, INC.

Principal $125,100; purchased at $104,250 (16.6% OID); 8% annual interest; matures June 27, 2024.
Conversion after 180 days at 85% of lowest trading price in prior 20 days; 4.99% ownership cap.
Company granted 1800 Diagonal Lending right of first refusal on future equity offerings under $150k for 9 months.
Proceeds used for general working capital; buyer's expenses of $4,250 reimbursed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.